Carcinoma Arising in Bowen's Disease

Kao, Grace F.

doi:10.1001/archderm.1986.01660220042010

Cited by 206 publications

(152 citation statements)

References 7 publications

Supporting

Mentioning

145

Contrasting

Unclassified

Order By: Relevance

“…Most studies suggest a risk of invasive carcinoma of about 3-5% for typical SCC in situ, 33,34 and about 10% for EQ. 3 In bowenoid papulosis, invasion is extremely rare.…”

Section: Risk Of Progression To Squamous Cell Carcinomamentioning

confidence: 99%

BritishAssociation ofDermatologists' guidelines for the management of squamous cell carcinomain situ(Bowen's disease) 2014

et al. 2014

View full text Add to dashboard Cite

“…Most studies suggest a risk of invasive carcinoma of about 3-5% for typical SCC in situ, 33,34 and about 10% for EQ. 3 In bowenoid papulosis, invasion is extremely rare.…”

Section: Risk Of Progression To Squamous Cell Carcinomamentioning

confidence: 99%

BritishAssociation ofDermatologists' guidelines for the management of squamous cell carcinomain situ(Bowen's disease) 2014

et al. 2014

View full text Add to dashboard Cite

“…Bowen's disease is carcinoma in-situ with potential of lateral spread. [1,2] It is clinically found in elderly person as a solitary irregular well-defi ned scaly plaque on sun-exposed part of the body. [3][4][5][6][7].…”

mentioning

confidence: 99%

Multiple Bowen′s disease in chronic arsenicosis

Singha¹

2014

Int J Med Public Health

View full text Add to dashboard Cite

“…Progression to an invasive SCC has been observed in up to 33% of cases of EQ, with metastases occurring in about 20% of patients with invasive carcinoma 2 . In contrast, progression to invasive SCC from BD was seen in approximately 3% for cutaneous 3,4 and 10% for genital lesions 3 . It is suggested that EQ has a greater chance of becoming a malignancy than BD of the skin.…”

Section: Discussionmentioning

confidence: 92%

A Case of Erythroplasia of Queyrat Treated with Imiquimod 5% Cream and Excision

Choi

Cho

2009

Ann Dermatol

View full text Add to dashboard Cite

Imiquimod is a new immunomodulating agent with antitumor and antiviral properties that has been shown to be clinically effective in various kinds of skin diseases, including precancerous dermatoses. Erythroplasia of Queyrat is a carcinoma in situ that mainly occurs on the glans penis. There are several non-invasive treatment options for erythroplasia of Queyrat such as photodynamic therapy, cryosurgery and applying various kinds of topical agents. We now report a case of typical erythroplasia of Queyrat on glans penis associated with human papillomavirus type 16 infection that was treated by imiquimod 5% cream and the subsequent excision of an imiquimod-resistant penile lesion.

show abstract

Carcinoma Arising in Bowen's Disease

Cited by 206 publications

References 7 publications

BritishAssociation ofDermatologists' guidelines for the management of squamous cell carcinomain situ(Bowen's disease) 2014

BritishAssociation ofDermatologists' guidelines for the management of squamous cell carcinomain situ(Bowen's disease) 2014

Multiple Bowen′s disease in chronic arsenicosis

A Case of Erythroplasia of Queyrat Treated with Imiquimod 5% Cream and Excision

Contact Info

Product

Resources

About